OM:NGS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

NGS Group AB (publ) provides recruitment and staffing services in the healthcare, school, social services, and finance areas in Sweden, Norway, and Finland. More Details


Snowflake Analysis

Undervalued with excellent balance sheet.


Similar Companies

Share Price & News

How has NGS Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NGS has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0.3%

NGS

-3.8%

SE Healthcare

-1.1%

SE Market


1 Year Return

-26.4%

NGS

15.2%

SE Healthcare

13.4%

SE Market

Return vs Industry: NGS underperformed the Swedish Healthcare industry which returned 15.2% over the past year.

Return vs Market: NGS underperformed the Swedish Market which returned 13.4% over the past year.


Shareholder returns

NGSIndustryMarket
7 Day0.3%-3.8%-1.1%
30 Day3.7%3.1%2.7%
90 Day11.2%15.7%6.8%
1 Year-26.4%-26.4%15.2%15.2%15.3%13.4%
3 Year-66.3%-69.4%1.4%-0.9%30.9%16.9%
5 Year-54.7%-61.7%-12.0%-18.1%59.3%28.3%

Price Volatility Vs. Market

How volatile is NGS Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is NGS Group undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: NGS (SEK15.45) is trading below our estimate of fair value (SEK76.55)

Significantly Below Fair Value: NGS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: NGS is good value based on its PE Ratio (15.1x) compared to the SE Healthcare industry average (20.7x).

PE vs Market: NGS is good value based on its PE Ratio (15.1x) compared to the Swedish market (22x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NGS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NGS is good value based on its PB Ratio (0.6x) compared to the SE Healthcare industry average (1.4x).


Next Steps

Future Growth

How is NGS Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

47.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as NGS Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has NGS Group performed over the past 5 years?

-11.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NGS has high quality earnings.

Growing Profit Margin: NGS's current net profit margins (1.9%) are lower than last year (3.4%).


Past Earnings Growth Analysis

Earnings Trend: NGS's earnings have declined by 11.7% per year over the past 5 years.

Accelerating Growth: NGS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: NGS had negative earnings growth (-54.4%) over the past year, making it difficult to compare to the Healthcare industry average (-18%).


Return on Equity

High ROE: NGS's Return on Equity (4.1%) is considered low.


Next Steps

Financial Health

How is NGS Group's financial position?


Financial Position Analysis

Short Term Liabilities: NGS's short term assets (SEK82.1M) exceed its short term liabilities (SEK80.8M).

Long Term Liabilities: NGS's short term assets (SEK82.1M) exceed its long term liabilities (SEK6.9M).


Debt to Equity History and Analysis

Debt Level: NGS's debt to equity ratio (8.9%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if NGS's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: NGS's debt is well covered by operating cash flow (147.7%).

Interest Coverage: NGS's interest payments on its debt are well covered by EBIT (8.1x coverage).


Balance Sheet


Next Steps

Dividend

What is NGS Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NGS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NGS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NGS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NGS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: NGS is not paying a notable dividend for the Swedish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NGS's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.1yrs

Average board tenure


CEO

Ingrid Nordlund (52 yo)

12.75yrs

Tenure

kr3,519,960

Compensation

Ms. Ingrid Nordlund has been the Chief Executive Officer of NGS Group AB (publ) since 2008. Ms. Nordlund is a Director of Transcendent Group AB (publ) since 2018. Ms. Nordlund serves as the Chairman of the ...


CEO Compensation Analysis

Compensation vs Market: Ingrid's total compensation ($USD401.29K) is above average for companies of similar size in the Swedish market ($USD231.20K).

Compensation vs Earnings: Ingrid's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Ulf Barkman
Independent Director4.75yrskr125.00k0.44%
SEK 618.0k
Gerth Svensson
Independent Director1.42yrskr50.00k0.033%
SEK 46.4k
Charlotte Pantzar Huth
Director2.75yrsno data2.4%
SEK 3.4m
Bertil Johanson
Independent Chairman of the Board1.42yrskr225.00k0.022%
SEK 30.9k

2.1yrs

Average Tenure

58.5yo

Average Age

Experienced Board: NGS's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

NGS Group AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: NGS Group AB (publ)
  • Ticker: NGS
  • Exchange: OM
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: kr139.400m
  • Shares outstanding: 9.02m
  • Website: https://www.ngsgroup.se

Number of Employees


Location

  • NGS Group AB (publ)
  • Kungsgatan 12
  • Stockholm
  • Stockholm County
  • 111 35
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NGSOM (OMX Nordic Exchange Stockholm)YesCommon SharesSESEKFeb 2007
0RPCLSE (London Stock Exchange)YesCommon SharesGBSEKFeb 2007

Biography

NGS Group AB (publ) provides recruitment and staffing services in the healthcare, school, social services, and finance areas in Sweden, Norway, and Finland. The company is based in Stockholm, Sweden.


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/25 20:54
End of Day Share Price2020/10/23 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.